Bio News
A research team led by Won-Seok Jung at the Korea Advanced Institute of Science and Technology identified the ERBB4 receptor in excitatory neurons, rather than inflammation, as an early disease-onset switch in Alzheimer disease. In the 5×FAD mouse model, the team found that removing ERBB4 from excitatory neurons reversed abnormal synaptic pruning and cognitive decline. Conversely, overexpressing only ERBB4 in the excitatory neurons of normal mice produced Alzheimer disease-like symptoms without amyloid plaques.
Biobook Team
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
